Patented medicines will be offered at a not-for-profit price - which the boss says may benefit more than one-billion people.
Albert Bourla from the Tadworth based pharma giant says he's proud of his company
He also commented on the rise in monkeypox cases in Europe - but believes coronavirus is a bigger threat.